AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Surmodics to Webcast Third Quarter Fiscal 2019 Earnings Conference Call on July 31

July 23, 2019

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jul 23, 2019--

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, president and chief executive officer, and Tim Arens, vice president of finance and chief financial officer, will recap the third quarter fiscal 2019 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at https://surmodics.gcs-web.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7 p.m. CT on Wednesday, July 31, until 7 p.m. CT on Wednesday, August 7, and can be accessed by dialing 888-203-1112 and entering conference call ID passcode 6653187. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address unmet clinical needs for its medical device customers and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190723005129/en/

CONTACT: Tim Arens

952-500-7000

ir@surmodics.com

KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES ENGINEERING MANUFACTURING BIOTECHNOLOGY HEALTH SCIENCE OTHER SCIENCE

SOURCE: Surmodics, Inc.

Copyright Business Wire 2019.

PUB: 07/23/2019 08:30 AM/DISC: 07/23/2019 08:31 AM

http://www.businesswire.com/news/home/20190723005129/en

All contents © copyright 2019 The Associated Press. All rights reserved.